Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. - Wikidata - wikimedia - TriplyDB

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

http://www.wikidata.org/entity/Q33459535

about

Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review Timeliness of clinic attendance is a good predictor of virological response and resistance to antiretroviral drugs in HIV-infected patients Plasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-western Tanzania Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort.Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015.Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp Adherence to Antiretroviral Therapy Among Children Living with HIV in South India.Adherence to highly active antiretroviral treatment in HIV-infected Rwandan women.Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome Treatment initiation, program attrition and patient treatment outcomes associated with scale-up and decentralization of HIV care in rural Malawi.Effective coverage for antiretroviral therapy in a Ugandan district with a decentralized model of care.SAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settings Characterization of treatment failure in HIV positive patients in the Colombian Caribbean region.Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy What Time is it? Adherence to Antiretroviral Therapy in Ethiopia.First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.Determinants of virological failure and antiretroviral drug resistance in Mozambique.Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.Virologic and Immunologic Outcomes of the Second-Line Regimens of Antiretroviral Therapy Among HIV-Infected Patients in Thailand.Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism."It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia.Scaling up implementation of ART: Organizational culture and early mortality of patients initiated on ART in Nairobi, Kenya.Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.Clinical, Immunological and Virological Responses of Zidovudine-Lamivudine-Nevirapine versus Zidovudine-Lamivudine-Efavirenz Antiretroviral Treatment (ART) Among HIV-1 Infected Children: Asella Teaching and Referral Hospital, South-East Ethiopia.Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.Adherence to Highly Active Antiretroviral Therapy Among Children in Ethiopia: A Systematic Review and Meta-analysis

P2860

Q26823588-6A26C167-B06C-4BDE-A4D7-411A107E125F Q28484929-C9B6C790-E59E-460A-9829-6C785D7DA35D Q28533168-6930016D-B592-48EA-9CB2-7CE14F76F9D1 Q31150044-6F886D43-9D7E-477D-AD2D-F808407B1883 Q33582022-661F4337-A886-49A8-B5B7-E36CF9693091 Q33584656-BD6F4A09-36AE-49AC-8278-C29E02E6C1A0 Q33619740-F995B0A8-737E-444B-969C-550B866CAF8D Q33634625-84DC9F73-00C2-40BD-804B-D98F4625C4AF Q33742478-30B5F588-06B1-468A-8CB4-956B78F1417B Q33803772-77CE2C13-3E32-45FF-AFD3-72E955CDD90F Q34082897-CB1EAE25-A10D-465D-BF52-FA0693384AC8 Q34222186-CD2AA2D7-E304-44FD-B84C-47EDC4A47D92 Q34292437-5C881BC1-360D-4723-A246-05CF30669B80 Q34450196-648F0987-5ABA-4CE9-9182-A5A7CEC8A6F1 Q34920087-72885155-5781-4E0D-A1C6-7B4ED89D260A Q35035797-A3D51309-888F-44D7-B5CC-912AFC06597D Q35149749-EDCC7F0E-98E9-420C-ADF0-D5D463B2C6BC Q36090721-A5EB1D1B-27B4-4D9E-9FE1-91B99BBB1053 Q37171089-E95567A4-68E7-474D-9F5C-06E1A3078793 Q37241902-3675957D-2171-4993-B655-797BB89F6E9E Q37284765-46536DDD-1C66-4A23-BC8C-A01EB6C8DCA8 Q37582314-E10D41F0-44CF-489E-B19B-4C8B9B21E21D Q37699575-764294C3-34DE-41C7-A2B9-BAA3D2F62A72 Q38954109-8E0D9390-8729-44CA-B68E-4EAC833273F6 Q39414398-08ED76C6-A3C2-46CC-AF76-D445FE61AA68 Q39557809-E197AB1B-6838-4FD2-9CEB-A04D5CFE7B06 Q39597533-7B43B07D-FB1A-4C9B-B151-F6992FB8BFF2 Q42251901-06F8DA73-1C95-45AF-A3A8-0A91E9E0B93B Q44526447-FF1C7BF6-1921-4C3C-A24F-5E299EFD11FE Q47115571-9B681FE3-65F0-4BBE-A1AD-19461A80C4CB Q47223924-C7D4F08E-0FAA-47B7-8140-CE8EB07E69B2 Q47547888-1F0909AA-499F-48EA-9F8D-F3AAA0302230 Q55417509-9F32B296-3BB1-46AC-9EFD-D32632CD3765 Q55519161-50517D87-AB79-4AAD-8E0C-1E9BAB410FF8 Q58848755-0448469D-C2A4-4CEE-9EC2-8FE705756048

P2860

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

http://www.wikidata.org/entity/Q33459535

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Risk factors for virological f ...... in rural northwestern Uganda.

@ast

Risk factors for virological f ...... in rural northwestern Uganda.

@en

type

label

Risk factors for virological f ...... in rural northwestern Uganda.

@ast

Risk factors for virological f ...... in rural northwestern Uganda.

@en

prefLabel

Risk factors for virological f ...... in rural northwestern Uganda.

@ast

Risk factors for virological f ...... in rural northwestern Uganda.

@en

P1433

Q33459535-FE4D0248-8A50-4623-A668-2AC4E16EB038

P1476

Q33459535-F0CCF865-875C-44A4-B701-7B3AC5951352

P2093

Q33459535-1F56B112-D550-4760-A679-D79C6F7C9BBF

Q33459535-23F6AB84-DDBA-4BC5-8B22-CFD762A86618

Q33459535-4D35D4A6-C226-4B82-8E85-09045C6F3F52

Q33459535-4F2EF480-C56D-4A1F-A076-29501DD36915

Q33459535-5126241D-065A-4C24-A4BA-B949FDC59A6B

Q33459535-A77648E2-5A02-4478-9169-FEB7487E7326

Q33459535-B438DB39-1217-4677-81FB-539E31A721DE

Q33459535-BBD64E38-FA5F-47D4-9177-D707193FC17C

Q33459535-C740816B-1660-448F-A4F0-495AD9A59725

P2860

Q33459535-034883FE-C44A-464A-9ED8-DE50A729A3E3

Q33459535-0A7DFAB2-FBBA-4F9B-9B94-258996FA9E58

Q33459535-15C53A33-8DAB-41FF-AAB7-DB68C4B87E92

Q33459535-22D49D1B-A046-4DF7-A31D-28A2AB115216

Q33459535-241D549E-C80C-4A8B-B4F4-43A87BA9AF66

Q33459535-25C9545C-57FF-4FC5-A6A7-59A3842476E7

Q33459535-282FC94B-1B07-4D21-BACD-4DFF74D46ECB

Q33459535-30D79F22-679B-478C-B906-32AA49626665

Q33459535-36724755-3A97-4677-917B-F0A0AF09C326

Q33459535-37AE53EC-641A-427E-BCBC-40DA0946388C

P2888

Q33459535-DC266BDD-B176-4C05-9945-6C3B183B549C

P304

Q33459535-7946D1E2-F6FA-4086-9A4C-E07C72A79C0A

P31

Q33459535-366068A4-C134-4FBB-A1E3-C6404952C74E

P356

Q33459535-F00E79A4-D277-4F9E-A52B-0BF875DA5B02

P478

Q33459535-20D349DB-3F21-4E88-B189-CB1386C3B90B

P50

Q33459535-89C68FA7-BF78-45E5-8770-878E8BE78EF9

P577

Q33459535-34598617-BE39-4DC8-8E88-3C81816F0AA6

P5875

Q33459535-1A9FBD08-1F3B-44C7-9314-A7A6DEDDEE47

P6179

Q33459535-01E3E0BD-C5EA-4DD5-ACA9-76D27698F621

P698

Q33459535-CBDBA098-1690-4C31-A512-EEC90A8AB951

P921

Q33459535-3CC2CB13-8D45-469F-BB6D-146DC967DA93

Q33459535-72B1392B-8689-4B9D-99B6-22A959E62410

Q33459535-BF191DB6-F7E9-43BC-A988-1C0E4EF4EE55

P932

Q33459535-BD361FA9-1E51-4008-AB92-71DF6AA5E221

P356

P1433

BMC Infectious Diseases

P1476

Risk factors for virological f ...... d in rural northwestern Uganda

@en

P2093

Charles Olaro

http://www.w3.org/2001/XMLSchema#string

Clotilde Le Tiec

http://www.w3.org/2001/XMLSchema#string

David Olson

http://www.w3.org/2001/XMLSchema#string

Gunar Guenther

http://www.w3.org/2001/XMLSchema#string

Laurence Ahoua

http://www.w3.org/2001/XMLSchema#string

Loretxu Pinoges

http://www.w3.org/2001/XMLSchema#string

Marie-Laure Chaix

http://www.w3.org/2001/XMLSchema#string

Paul Anguzu

http://www.w3.org/2001/XMLSchema#string

Suna Balkan

http://www.w3.org/2001/XMLSchema#string

P2860

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Nutrition and HIV/AIDS in sub-Saharan Africa: an overview.

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi.

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.

P2888

P304

81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-9-81

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Mar Pujades-Rodríguez

P577

2009-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26263780

http://www.w3.org/2001/XMLSchema#string

P6179

1043614962

http://www.w3.org/2001/XMLSchema#string

P698

19493344

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2701435

http://www.w3.org/2001/XMLSchema#string